FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to medicine and veterinary. Application of bacillus subtilis tv 06 recombinant strains as producers of glutamylendopeptidase - a substance with thrombolytic and anticoagulant properties - is proposed.
EFFECT: invention provides more efficient lysis (dissolution) of the thrombus, acceleration of thrombolysis process without adverse effects, prevention of blood clots formation in the circulatory system of the body and improved performance and quality of treatment.
3 cl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF RECOMBINANT STRAIN OF BACILLUS SUBTILIS EO-11 RNCIM B-11978 AS THE PRODUCT OF SUBTITLISIN-LIKE PROTEINASE, SUBSTANCES WITH THROMBOLYTIC AND ANTICOAGULANT PROPERTIES | 2015 |
|
RU2622006C2 |
METHOD OF PRODUCING ANTICOAGULATIVE COLLAGENASE INHIBITOR FROM KING CRAB HEPATOPANCREAS | 2009 |
|
RU2403284C1 |
METHOD FOR IMMOBILIZING AN ENZYME, SUBTILISIN-LIKE PROTEINASE, PRODUCED BY A BACTERIUM STRAIN OF THE GENUS BACILLUS OF THE SPECIES BACILLUS SP_ 7P/3-19, ON THE INSTRUMENT | 2017 |
|
RU2663128C1 |
IMMOBILISED BACILLUS LICHENIFORMIS BACTERIA PRODUCED SUBTILISIN SHOWING THROMBOLYTIC AND ANTICOAGULANT PROPERTIES | 2008 |
|
RU2416643C2 |
METHOD OF PRODUCTION OF PLASMINOGEN ACTIVATOR | 2007 |
|
RU2346983C1 |
METHOD FOR DETERMINATION OF FUNCTIONAL FIBRINOGEN | 2017 |
|
RU2669796C1 |
METHOD FOR DETECTING HEPARIN IN BLOOD | 2017 |
|
RU2662171C1 |
METHOD OF ESTIMATING CONDITION OF BLOOD COAGULATION SYSTEM IN PATIENTS IN CRITICAL CONDITION | 2012 |
|
RU2517116C2 |
STABILIZED STREPTOKINASE POSSESSING THROMBOLYTIC ACTIVITY | 0 |
|
SU822551A1 |
METHOD OF TREATING ACUTE THROMBOSIS OF RETINA VEINS | 2010 |
|
RU2416402C1 |
Authors
Dates
2017-02-21—Published
2015-05-08—Filed